Home

About Us Contact Us Products Articles
Categories

Antibiotics


Archives

February 2012

January 2012

December 2011

November 2011

October 2011


Articles

Bone cancer

Thu,09 February 2012 BONE CANCER develops most often in young people aged 10-20 years. Unlike almost all other "painless" types of cancer early symptom of bone cancer is usually a pain. Sometimes the

see more...

Soy allergy

Sat,11 February 2012 Soy allergy affects approximately 1 percent of people in the United States. Soy, also called soya, is among the top eight most common foods that trigger allergies in children. In many cases soy

see more...

How to boost your 'good' cholesterol

Wed,01 February 2012 Your doctor says you need to lower your low-density lipoprotein (LDL) cholesterol, what's often called the "bad" cholesterol. You're working hard at that goal, but now your doctor says it

see more...

What is type 2 diabetes?

Sun,29 January 2012 Type 2 diabetes is a lifelong disease that happens when the cells of the body can't use insulin the right way or when the pancreas can't make enough insulin. Insulin lets blood sugar—also cal

see more...

Managing Your Diabetes Risk

Fri,27 January 2012 By now, most people know that diabetes is a significant and growing public health problem. Here are some of the major risk factors for this disorder, along with some tips you can put into play righ

see more...


Interesting Facts


Tags

Vaccines Against Mycoplasma

Maruyama vaccine is similar to BCG vaccine, both of which are made from mycobacteria tuberculosis isolates. Murayama vaccine is made from mycobacteria tuberculosis isolates, and BCG is derived from an attenuated bovine tuberculosis bacillus. Maruyama vaccine, invented by Dr. Chisato Maruyama more than 50 years ago, can be used by itself or in combination with standard therapies. You can find medications at affordable prices in our online pharmacy. Murayama vaccine is approved by the FDA to treat terminal cancer patients.

Some forms of health insurance will cover the cost if the vaccine is used as part of standard therapy, because it is officially approved only as an immune system stimulant to counteract the side effect of bone marrow suppression caused by radiotherapy. Mycoplasmal infections are treatable with long cycles of high-dose antibiotics such as doxycycline and tetracycline, followed by a long period of low dose antibiotics. Maruyama vaccine is supplied by The Research Institute of Vaccine Therapy for Tumors and Infections Disease, Nippon Medical School Hospital in Tokyo, as long as the patient supplies a request from their physician. According to an article published in Cancer Detection And Prevention, 2003, by Tetsuo Kimoto M.D., Ph.D., Maruyama vaccine does not have direct cytotoxic effects on tumors, but rather causes their encapsulation by collagen fibers.

This leads to the containment and sometimes necrosis of tumors and their metastasis. Survival time increased in both animal and human subjects with tumors, and Kimoto stated that Murayama vaccine may benefit patients in whom the tumor is inoperable and resistant to conventional chemotherapy. Cervical cancer, caused by the human papilloma virus, strikes more than 10,000 USA women every year, killing more than 3,700. A new vaccine against the virus, Gardasil, was approved by the FDA in 2006. The vaccine is effective against HPV types 16 and 18, which cause about 70% of cervical cancers and against HPV types 6 and 11, which cause approximately 90% of genital warts.

May,2012    All right reserved. Free Web Templates